This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bussemakers, M. J. G. Articles by Schalken, J. A. Search for Related Content PubMed PubMed Citation Articles by Bussemakers, M. J. G. Articles by Schalken, J. A.

Decreased Expression of E-Cadherin in the Progression of Rat Prostatic Cancer¹

Urological Research Laboratory, Radboud University Hospital, P. O. Box 9101, 6500 HB Nijmegen, the NEtherlands [M. J. G. B., R. J. A. v. M., L. A. G., F. M. J. D., J. A. S.]; Oncology Center, The Johns Hopkins Hospital, Baltimore, Maryland 21205 [T. I., J. T. I.]; and Department of Biophysics, Kyoto University, Kitashirakawa, Sakyo-ku, Kyoto 606, Japan [M. T.]

Cadherins represent a family of Ca²⁺-dependent cell adhesion molecules involved in homotypic, homophilic cell-cell interactions. Recent studies have shown that the cadherins can play a role in invasive and metastatic behavior. Using the established Dunning R-3327 model system of serially transplantable rat prostate cancers, the expression of E- and P-cadherin in rat prostatic cancer was studied. Analysis within this system demonstrated that whereas E-cadherin was expressed in the normal rat prostate and the well- or moderately differentiated, noninvasive Dunning tumors, no expression, either at the mRNA or at the protein level, could be detected in the invasive sublines. Since not all invasive Dunning tumors studied have metastatic ability, these results suggest that a decreased expression of E-cadherin is correlated with invasive behavior rather than with metastatic ability.

Recently, genetic instability occurred in an animal bearing the well differentiated, androgen-responsive, slow growing, nonmetastatic Dunning R-3327-H rat prostate cancer resulting in the progression to an anaplastic, androgen-independent, fast growing, highly metastatic state. This spontaneously arising tumor, termed the AT6 subline, in its original host was heterogeneously composed of both a well differentiated and an anaplastic population of cancer cells in which areas of squamous cell differentiation were occasionally observed. The original animal bearing this heterogeneous AT6 cancer developed multiple metastases, the lung metastases being heterogeneously composed of anaplastic and squamous cell populations. Cytogenetic analysis demonstrated that the lung metastases were derived from a specific subpopulation of cancer cells present in the original AT6 primary tumor. Immunohistochemical studies demonstrated that only the area of lung metastases displaying squamous morphology were positive for E-cadherin. In contrast, the anaplastic areas of the lung metastases and the metastases in other organs were E-cadherin negative. By the first passage of the AT6 tumor only the anaplastic cells were present and no detectable E-cadherin mRNA or protein was found in the primary tumor and metastatic deposits. These results suggest that a decreased expression of E-cadherin is associated with the progression of prostatic cancer.

¹ These studies were supported by the Dutch Cancer Foundation (NUKC90-01) and the Royal Dutch Academy of Arts and Sciences (J. A. S.).

² To whom requests for reprints should be addressed.

Received 10/21/91. Accepted 3/11/91.

This article has been cited by other articles:

				D. Lin, A. Watahiki, J. Bayani, F. Zhang, L. Liu, V. Ling, M. D. Sadar, J. English, L. Fazli, A. So, et al. ASAP1, a Gene at 8q24, Is Associated with Prostate Cancer Metastasis Cancer Res., June 1, 2008; 68(11): 4352 - 4359. [Abstract] [Full Text] [PDF]

				S. Dalrymple, L. Antony, Y. Xu, A. R. Uzgare, J. T. Arnold, J. Savaugeot, L. J. Sokoll, A. M. De Marzo, and J. T. Isaacs Role of Notch-1 and E-Cadherin in the Differential Response to Calcium in Culturing Normal versus Malignant Prostate Cells Cancer Res., October 15, 2005; 65(20): 9269 - 9279. [Abstract] [Full Text] [PDF]

				W. Xia, P. Unger, L. Miller, J. Nelson, and I. H. Gelman The Src-suppressed C Kinase Substrate, SSeCKS, Is a Potential Metastasis Inhibitor in Prostate Cancer Cancer Res., July 1, 2001; 61(14): 5644 - 5651. [Abstract] [Full Text] [PDF]

				H. Habermann, W. Y. Chang, L. Birch, P. Mehta, and G. S. Prins Developmental Exposure to Estrogens Alters Epithelial Cell Adhesion and Gap Junction Proteins in the Adult Rat Prostate Endocrinology, January 1, 2001; 142(1): 359 - 369. [Abstract] [Full Text] [PDF]

				J. Luo, D. M. Lubaroff, and M. J. C. Hendrix Suppression of Prostate Cancer Invasive Potential and Matrix Metalloproteinase Activity by E-Cadherin Transfection Cancer Res., August 1, 1999; 59(15): 3552 - 3556. [Abstract] [Full Text] [PDF]

				R. H. Rondinelli and J. V. Tricoli CLAR1, a Novel Gene That Exhibits Enhanced Expression in Advanced Human Prostate Cancer Clin. Cancer Res., June 1, 1999; 5(6): 1595 - 1602. [Abstract] [Full Text] [PDF]

				E. Ruijter, C. van de Kaa, G. Miller, D. Ruiter, F. Debruyne, and J. Schalken Molecular Genetics and Epidemiology of Prostate Carcinoma Endocr. Rev., February 1, 1999; 20(1): 22 - 45. [Abstract] [Full Text]

				J. DePasquale, W. Samsonoff, and J. Gierthy 17-beta-Estradiol induced alterations of cell-matrix and intercellular adhesions in a human mammary carcinoma cell line J. Cell Sci., January 5, 1994; 107(5): 1241 - 1254. [Abstract] [PDF]